Our website uses cookies to ensure you get the best experience with the most relevant info provided

Cardiolyse is the WINNER of the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma

During months of dedicated work with 1-to-1 workshops with Amgen, Bayer, Beiersdorf, and Boehringer Ingelheim Cardiolyse amongst other 16 startups met the representatives from the pharma companies. All of the startups were given the opportunity to pitch our solutions to the pharma companies, who helped us validate the business concepts and provide us with critical feedback on our development plans. 

The Amgen Challenge is dedicated to encouraging continuity in treatment strategy and treatment optimization for post-myocardial infarction patients

Cardiolyse presented to AMGEN our Post Myocardium Infarction Rehabilitation Remote monitoring Platform that delivers a predictive analytic tool to identify high-risk patients and holistic support to post-MI patients after hospital discharge.

These tools provide essential information for patients' treatment strategies and lifestyle changes, optimizing nursing time in the follow-up of patients.

We are thrilled to announce that Cardiolyse won the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma at the final Module 3.

Back to blog

Related posts

Cardiolyse crowdfunding open on Aescuvest.de

Cardiolyse shows a successful pilot project at EXPO 6 Startup Creasphere by Plug and Play

EIT Health Catapult 2021 selects Cardiolyse for the semi-final

Cardiolyse is chosen for the first edition of the Health&Biotech accelerator by Deloitte Italy

Startup Creasphere by Plug and Play selects Cardiolyse for their 3-months-program

Read more

Let’s work together
on heart health improvement